These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23132723)

  • 21. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
    Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
    J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.
    Michel ML; Loirat D
    Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds.
    Qian B; Shen H; Liang W; Guo X; Zhang C; Wang Y; Li G; Wu A; Cao K; Zhang D
    Transgenic Res; 2008 Aug; 17(4):621-31. PubMed ID: 17882531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structure of hepatitis B envelope and molecular variants of hepatitis B virus.
    Howard CR
    J Viral Hepat; 1995; 2(4):165-70. PubMed ID: 7489342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants.
    Lou XM; Yao QH; Zhang Z; Peng RH; Xiong AS; Wang HK
    Clin Vaccine Immunol; 2007 Apr; 14(4):464-9. PubMed ID: 17314228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of hepatitis B surface antigen in recombinant plant systems: an update.
    Kumar GB; Ganapathi TR; Bapat VA
    Biotechnol Prog; 2007; 23(3):532-9. PubMed ID: 17348684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of plant-based mucosal vaccines against widespread infectious diseases.
    Salyaev RK; Rigano MM; Rekoslavskaya NI
    Expert Rev Vaccines; 2010 Aug; 9(8):937-46. PubMed ID: 20673015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccines.
    Shouval D
    J Hepatol; 2003; 39 Suppl 1():S70-6. PubMed ID: 14708681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine.
    Pillot J; Poynard T; Elias A; Maillard J; Lazizi Y; Brancer M; Dubreuil P; Budkowska A; Chaput JC
    Vaccine; 1995 Feb; 13(3):289-94. PubMed ID: 7631515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis.
    Zhang Q; Li ZQ; Liu H; Yang JH
    World J Gastroenterol; 2012 Jan; 18(4):349-55. PubMed ID: 22294841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The obtaining of transgenic tomato plant producing chimerical proteins TBI-HBsAg.
    Shchelkunov SN; Salyaev RK; Rekoslavskaya NI; Ryzhova TS; Pozdnyakov SG; Sumtsova VM; Pakova NV; Mishutina UO; Kopytina TV; Hammond R
    Dokl Biochem Biophys; 2004; 396():139-42. PubMed ID: 15378910
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.
    Rendi-Wagner P; Shouval D; Genton B; Lurie Y; Rümke H; Boland G; Cerny A; Heim M; Bach D; Schroeder M; Kollaritsch H
    Vaccine; 2006 Apr; 24(15):2781-9. PubMed ID: 16455169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2 + S vaccine.
    Hurni WM; Roehm RR; Miller WJ
    J Med Virol; 1990 Feb; 30(2):146-50. PubMed ID: 2313274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
    Cornelius C; Schöneweis K; Georgi F; Weber M; Niederberger V; Zieglmayer P; Niespodziana K; Trauner M; Hofer H; Urban S; Valenta R
    EBioMedicine; 2016 Sep; 11():58-67. PubMed ID: 27568223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses to preS components after immunization of children with low doses of BioHepB.
    Madalinski K; Sylvan SP; Hellström U; Mikolajewicz J; Zembrzuska-Sadkowska E; Piontek E
    Vaccine; 2001 Oct; 20(1-2):92-7. PubMed ID: 11567751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Simultaneous expression of modified hepatitis B surface antigen fusion polypeptides containing preS1, preS2 epitopes in Pichia pastoris].
    Tan CY; Jiang LM; Ge YH; Yuan J; Jin O; Hu B
    Sheng Wu Gong Cheng Xue Bao; 2006 Jul; 22(4):604-8. PubMed ID: 16894895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Production of marker-free plants expressing the gene of the hepatitis B virus surface antigen].
    Rukavtsova EB; Gaiazova AR; Chebotareva EN; Bur'ianova IaI
    Genetika; 2009 Aug; 45(8):1055-60. PubMed ID: 19769294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [C3d enhances the immune response against HBV-preS2/S following gene immunization in mice].
    Guan QD; Wang LX; Guo Q; Zhang JP; Xu W; Wang Y; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):101-5. PubMed ID: 15774215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Humoral immunological response in laboratory animals after vaccination with recombinant vaccines against viral hepatitis B of different generations].
    Górska P
    Przegl Epidemiol; 2007; 61(2):393-400. PubMed ID: 17956059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.